One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine

Published:2023-01 Issue:4 Volume:41 Page:871-874
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Wand Ori,Breslavsky Anna,Bar-Shai Amir,Levy Chezy,Maayan Shlomo,Rimler Avi,Zwahra Moatasem,Cohen-Hagai Keren,Harish Alma,Zacks Nadav,Bilenko Natalya

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference15 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months;Thomas;N Engl J Med,2021

2. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers;Bergwerk;N Engl J Med,2021

3. Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years;Eliakim-Raz;JAMA,2021

4. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel;Bar-On;N Engl J Med,2021

5. Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England;Krutikov;Lancet Healthy Longev,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents—Georgia, October 2020–July 2022;PLOS ONE;2024-04-16

2. COVID-19 boosters versus primary series: update to a living review;The Lancet Respiratory Medicine;2023-10

3. Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID‐19 vaccine Ad26.COV2.S in humans;CPT: Pharmacometrics & Systems Pharmacology;2023-09-15

4. Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination;Microbiology Spectrum;2023-06-15

5. mRNA Vaccines against SARS-CoV-2: Advantages and Caveats;International Journal of Molecular Sciences;2023-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3